BX generics indicate what about data?

• A. Data is insufficient to determine therapeutic equivalence
• B. Equivalent classification by FDA
• C. Bioequivalence problems
• D. Not approved for use

Answer: (A)

BX signals that the available data do not allow a determination of bioequivalence to the reference product. Therapeutic equivalence means the generic should deliver the same clinical effect and safety profile, so when BX is shown, you can’t assume interchangeability because more data or studies are needed to confirm BE. It isn’t a statement that the product isn’t approved, nor that there are proven BE problems, and it doesn’t indicate an equivalent FDA classification (that would be AB). So the main idea is that the data are insufficient to decide therapeutic equivalence.